INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
SEC FORM 4/Derivative conversionVerified dataRule 10b5-1 plan

Perez Daniel Antonio reported HNGE

Director, CEO & Co-Founder, 10% Owner · Hinge Health, Inc. · Hinge Health, Inc. — Class B Common Stock

Side
C
Value
—
Shares
166.7K
Price
—
Executed
Feb 12, 2026
Disclosed
Feb 13, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Feb 12 executedFeb 13, 2026 disclosed

HNGE · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
0/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Derivative conversion — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · 1.8% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+4 / 15

    4 prior trades recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · HNGE

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    8
    PJ
    Pursley JamesPresident
    HNGEHinge Health, Inc.
    Tax withholding
    		F$95K
    831 sh
    		Nov 1, 2026Nov 2, 2026
    traded Nov 1, 2026
    		+1dSEC FORM 4

    Evidence

    20
    MI
    Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
    HNGEHinge Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$9.38M
    91.5K sh
    		Oct 12, 2026Oct 13, 2026
    traded Oct 12, 2026
    		+1dSEC FORM 4

    Evidence

    9
    MI
    Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
    HNGEHinge Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$877K
    8,642 sh
    		Oct 12, 2026Oct 13, 2026
    traded Oct 12, 2026
    		+1dSEC FORM 4

    Evidence

    0
    MI
    Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
    HNGEHinge Health, Inc.
    Derivative conversion · 10b5-1 plan
    		C—
    200.0K sh
    		Oct 12, 2026Oct 13, 2026
    traded Oct 12, 2026
    		+1dSEC FORM 4

    Evidence

    24
    MI
    Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
    HNGEHinge Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$6.21M
    60.0K sh
    		Oct 12, 2026Oct 13, 2026
    traded Oct 12, 2026
    		+1dSEC FORM 4

    Evidence

    0
    MI
    Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
    HNGEHinge Health, Inc.
    Derivative conversion · 10b5-1 plan
    		C—
    200.0K sh
    		Oct 12, 2026Oct 13, 2026
    traded Oct 12, 2026
    		+1dSEC FORM 4

    Evidence

    24
    MI
    Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
    HNGEHinge Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$4.16M
    39.9K sh
    		Oct 12, 2026Oct 13, 2026
    traded Oct 12, 2026
    		+1dSEC FORM 4

    Evidence

    21
    PA
    Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
    HNGEHinge Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$411K
    4,100 sh
    		Oct 6, 2026Oct 7, 2026
    traded Oct 6, 2026
    		+1dSEC FORM 4

    Evidence

    0
    PA
    Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
    HNGEHinge Health, Inc.
    Derivative conversion · 10b5-1 plan
    		C—
    4,100 sh
    		Oct 6, 2026Oct 7, 2026
    traded Oct 6, 2026
    		+1dSEC FORM 4

    Evidence

    0
    PA
    Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
    HNGEHinge Health, Inc.
    Derivative conversion · 10b5-1 plan
    		C—
    4,100 sh
    		Oct 6, 2026Oct 7, 2026
    traded Oct 6, 2026
    		+1dSEC FORM 4

    Evidence

    9
    ST
    Sloat TylerDirector
    HNGEHinge Health, Inc.
    Grant or award
    		A$16K
    175 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    8
    PJ
    Pursley JamesPresident
    HNGEHinge Health, Inc.
    Tax withholding
    		F$81K
    831 sh
    		Oct 1, 2026Oct 1, 2026
    traded Oct 1, 2026
    		+0dSEC FORM 4

    Evidence

    24
    PJ
    Pursley JamesPresident
    HNGEHinge Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$2.18M
    23.1K sh
    		Sep 21, 2026Sep 23, 2026
    traded Sep 21, 2026
    		+2dSEC FORM 4

    Evidence

    21
    PJ
    Pursley JamesPresident
    HNGEHinge Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$846K
    9,065 sh
    		Sep 21, 2026Sep 23, 2026
    traded Sep 21, 2026
    		+2dSEC FORM 4

    Evidence

    18
    PJ
    Pursley JamesPresident
    HNGEHinge Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$76K
    800 sh
    		Sep 21, 2026Sep 23, 2026
    traded Sep 21, 2026
    		+2dSEC FORM 4

    Evidence

    29
    MI
    Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
    HNGEHinge Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$3.15M
    33.5K sh
    		Sep 14, 2026Sep 15, 2026
    traded Sep 14, 2026
    		+1dSEC FORM 4

    Evidence

    0
    MI
    Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
    HNGEHinge Health, Inc.
    Derivative conversion · 10b5-1 plan
    		C—
    150.0K sh
    		Sep 14, 2026Sep 15, 2026
    traded Sep 14, 2026
    		+1dSEC FORM 4

    Evidence

    21
    MI
    Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
    HNGEHinge Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$1.52M
    16.5K sh
    		Sep 14, 2026Sep 15, 2026
    traded Sep 14, 2026
    		+1dSEC FORM 4

    Evidence

    21
    MI
    Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
    HNGEHinge Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$1.07M
    11.7K sh
    		Sep 14, 2026Sep 15, 2026
    traded Sep 14, 2026
    		+1dSEC FORM 4

    Evidence

    11
    MI
    Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
    HNGEHinge Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$249K
    2,800 sh
    		Sep 14, 2026Sep 15, 2026
    traded Sep 14, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002063236-26-000004
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Feb 12, 2026
    Published
    Feb 13, 2026
    Ingested by INSIDER
    Nov 5, 04:17 UTC
    Last re-read
    Nov 5, 04:17 UTC

    Extracted facts

    Filer
    Perez Daniel Antonio
    Role
    Director, CEO & Co-Founder, 10% Owner
    Transaction
    Derivative conversionAs filed: “C”
    Asset
    Hinge Health, Inc. — Class B Common Stock
    Ticker
    HNGE
    Shares
    166.7K
    Price per share
    $0
    Execution date (reported)
    Feb 12, 2026
    Owned after transaction
    9.49M shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    1

    What this establishes

    Perez Daniel Antonio filed this Form 4 reporting a derivative conversion of HNGE on Feb 12, 2026. It became public on Feb 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director, CEO & Co-Founder, 10% Owner
    Perez Daniel Antoniocik:0002063236
    Issuer
    Hinge Health, Inc.cik:0001673743

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.